Template:SubstanceBox/Memantine: Difference between revisions
From Drugwiki
Many users reporting memantine onset time being much shorter than those depicted in this page, some of them feeling a very subtle dissociation 30 minutes after ingestion. |
m 1 revision imported |
(No difference)
| |
Latest revision as of 14:18, 1 November 2025
{{#arraydefine: InhaledDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: InhaledDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: SmokedDosage |
Threshold;< x mg,
Light;x - x mg,
Common;x - x mg,
Strong;x - x mg,
Heavy;> x mg
}}
{{#arraydefine: SmokedDuration |
Total;x minutes,
Onset;x seconds,
Come up;,
Peak;x minutes,
Offset;x hours,
After effects;x hours
}}
{{#arraydefine: OralDosage |
Threshold;Oral threshold dose::10Oral dose units::mg,
Light;Oral min light dose::30 - Oral max light dose::70 mg,
Common;Oral min common dose::70 - Oral max common dose::110 mg,
Strong;Oral min strong dose::110 - Oral max strong dose::170 mg,
Heavy;Oral heavy dose::170 mg +
}}
{{#arraydefine: OralDuration |
Total;~ Oral min total time::18 - Oral max total time::36Oral total time units::hours,
Onset;Oral min onset time::30 - Oral max onset time::180Oral onset time units::minutes,
Come up;Oral min comeup time::2 - Oral max comeup time::3Oral comeup time units::hours,
Peak;Oral min peak time::3 - Oral max peak time::12Oral peak time units::hours,
Offset;Oral min offset time::5 - Oral max offset time::24Oral offset time units::hours,
After effects;Oral min afterglow time::8 - Oral max afterglow time::24Oral afterglow time units::hours
}}
{{#arraydefine: SublingualDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: SublingualDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: BuccalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: BuccalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: InsufflatedDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: InsufflatedDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: RectalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: RectalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: TransdermalDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: TransdermalDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: SubcutaneousDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: SubcutaneousDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: IntramuscularDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: IntramuscularDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: IntravenousDosage |
Threshold;,
Light;,
Common;,
Strong;,
Heavy;
}}
{{#arraydefine: IntravenousDuration |
Total;,
Onset;,
Come up;,
Peak;,
Offset;,
After effects;
}}
{{#arraydefine: uncertaininteractions
| {{#ask:SubstanceBox/Memantine
|?UncertainInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}}
{{#arraydefine: unsafeinteractions
| {{#ask:SubstanceBox/Memantine
|?UnsafeInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}}
{{#arraydefine: dangerousinteractions
| {{#ask:SubstanceBox/Memantine
|?DangerousInteraction
|headers=hide
|format=list
|mainlabel=-
|link=none
}}
}} {{#arrayprint:uncertaininteractions||@@@@|
}} {{#arrayprint:unsafeinteractions||@@@@|
}} {{#arrayprint:dangerousinteractions||@@@@|
}}
| SubstanceBox/Memantine | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemical Nomenclature | |||||||||||||||||
| Common names | common name::Memantine, common name::Memaxa, common name::Ebixa, common name::Namenda, common name::Namenda XR, common name::Namzaric (with donepezil, common name::both extended-release) | ||||||||||||||||
| Substitutive name | Memantine | ||||||||||||||||
| Systematic name | 3,5-Dimethyladamantan-1-amine | ||||||||||||||||
| Class Membership | |||||||||||||||||
| Psychoactive class | psychoactive class::Dissociative | ||||||||||||||||
| Chemical class | chemical class::Adamantane | ||||||||||||||||
| Routes of Administration | |||||||||||||||||
|
|||||||||||||||||
| Interactions | |||||||||||||||||
| @@@@ | |||||||||||||||||
| @@@@ | |||||||||||||||||
| @@@@ | |||||||||||||||||
- ↑ Lee, S.-H., Kim, S.-H., Noh, Y.-H., Choi, B.-M., Noh, G.-J., Park, W.-D., Kim, E.-J., Cho, I.-H., Bae, C.-S. (February 2016). "Pharmacokinetics of Memantine after a Single and Multiple Dose of Oral and Patch Administration in Rats". Basic & Clinical Pharmacology & Toxicology. 118 (2): 122–127. doi:10.1111/bcpt.12479. ISSN 1742-7843.
